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Abstract 
 
 
 Catalytic promiscuity provides a starting point for the evolution of new enzymes. 
When a secondary “promiscuous” activity becomes physiologically relevant, selection 
will favor genetic changes that improve upon this promiscuous activity. When the ability 
to do both activities limits growth, it is an inefficient bi-functional enzyme. The Copley 
lab at the University of Colorado at Boulder has found several genetic changes that 
increase fitness in a ΔargC strain of Escherichia coli BW25113 when growth is limited 
by an inefficient bi-functional enzyme (ProA*). The experiments described in this thesis 
investigate the genetic changes that increase fitness in a ΔargC strain of Salmonella 
enterica subsp. enterica serovar Typhimurium str. SL1344 when limited by a similar 
inefficient bi-functional enzyme. In addition to identifying specific genetic changes, I aim 
to investigate how differences in the genetic background and physiology of the organism 
affect what changes are selected for and the adaptive potential of such changes.   
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Chapter 1 
Introduction 
 
Promiscuous activity and the emergence of new enzymes 
Ohno was the first to suggest that duplication of a gene encoding an enzyme could 
allow extra copies of the gene to accumulate mutations leading to the emergence of a new 
enzymatic activity while one copy reserves the original function (19). If this new activity 
helps a cell outgrow other cells around it, then it has increased fitness and is under 
positive selection. The problem with this model is that gene duplication will not be 
maintained if there is no benefit from having multiple copies (3). In most cases, gene 
duplications are either selectively neutral or detrimental due to the fitness costs of their 
maintenance, limiting the ability of a cell to maintain duplicated copies long enough for 
beneficial mutations to occur (12). However, solutions to this problem have been 
proposed based on the observation that most new enzyme activities closely resemble the 
original activity of the enzyme. 
Active sites of specialized enzymes often bind molecules that have some 
resemblance to their natural or physiological substrates, although usually with much 
lower affinity (13). If an enzyme can bind an unintended substrate and catalyze a 
secondary reaction that is physiologically irrelevant, it is said to have “catalytic 
promiscuity” (9). If this secondary activity becomes physiologically relevant by 
increasing fitness, selection will favor genetic changes that take advantage of this new 
activity (10). The promiscuous activity of essential enzymes or those that are 
constitutively expressed are usually the first to be recruited in the face of an 
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environmental change due to their active and selectable presence in the cell (10). 
Alternatively, mutations that cause constitutive expression of non-essential genes that can 
be subsequently recruited to produce essential metabolites via their promiscuous 
activities have been documented (4, 23). In either case, promiscuous activities must be 
efficient enough to be physiologically sufficient, that is, the must affect the fitness of the 
cell by allowing survival or increasing growth rate.  
There are a multiple ways that a promiscuous activity can be raised to 
physiologically sufficient levels. On the one hand, duplication can increase the 
concentration of an enzyme with promiscuous activity in the cell allowing the unintended 
substrate to be catalyzed to physiologically sufficient levels. Furthermore, if this 
secondary activity becomes necessary for survival, then duplication would be maintained 
allowing the possible divergence of the duplicated copies (10). Overproduction of an 
enzyme resulting in the emergence of a new activity to replace critical enzymes, digest 
toxins, and facilitate alternative routes for synthesis of important metabolites has be 
shown to occur (15). If a new activity could be raised to physiologically sufficient levels 
via duplication, then this is really promising for the evolution of new enzymes. However, 
gene duplication could have varying fitness impacts depending on the genetic context of 
the duplication and the physiology of the organism. The idea that duplication interferes 
with highly constrained cellular systems is termed the dosage-balance hypothesis (8). 
Furthermore, many promiscuous activities are too inefficient to confer a fitness benefit 
even after duplication (8, 10).  
Alternatively, a mutation could increase the efficiency of the promiscuous activity 
to physiological sufficient levels without duplication. Mutations can cause structural 
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changes in the enzyme making it less conforming to its natural substrate and allowing this 
unintended substrate to more effectively compete (21). While such a mutation is very 
likely to have an impact on the necessary original activity of the enzyme and decrease 
fitness compared to the wild type, it selected for if it allows survival (17). This hypothesis 
predicts that a period of gene sharing is generally required for the emergence of new 
enzymatic activity (12). When the ability of an enzyme to do both activities limits growth 
of the cell, it is an inefficient bi-functional enzyme.   
Once a promiscuous activity is raised to physiologically sufficient levels, 
selection will favor changes that continue to improve fitness. Gene duplications can be 
selected for if increasing the concentration of the enzyme in the cell increases fitness. 
However, point mutations that increase the fitness of the cell by causing structural 
changes or increasing expression of the inefficient bi-functional enzyme are equally 
selectable if they increase fitness to the same degree. Most importantly, it is clear that 
gene duplication can occur and be maintained even after point mutations improve upon 
the inefficient bi-functional enzyme, as long as there is room to increase fitness (18). 
 The innovation, amplification, and divergence model describes this process and 
the adaptive potential of such an inefficient bi-functional enzyme. The Nasvall paper 
describes experiments studying this process in Salmonella enterica. They started with a 
trpF knockout that acquired an initial mutation in hisA allowing the recovery of the TrpF 
function that is necessary for survival. Both HisA and TrpF enzymes catalyze similar 
reactions involving isomerization of a phosphoribosyl compound, but each act on 
different substrates. Some of the mutants were able to increase fitness via amplification 
of the hisA gene while others acquired mutations increasing the efficiency of the bi-
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functional enzyme before amplification. After ~3000 generations, amplification allowed 
some copies to lose the previous mutation restoring HisA activity, while other copies 
acquired mutations increasing either TrpF activity or both activities. The gene for this bi-
functional enzyme was cloned onto a low-copy plasmid in order to decrease the time and 
fitness cost of amplification so that the process could be studied in a reasonable time (18). 
 
Specific Context and Aim of Project 
 The Copley lab at the University of Colorado Boulder is currently investigating 
the initial events after the emergence of an inefficient bi-functional enzyme that allows 
survival of a ΔargC strain of E. coli on minimal medium. Normally, this strain cannot 
grow on minimal medium (no amino acid supplements) because it lacks the ability to 
synthesize arginine. ProA is an enzyme encoded by proA in the proBA operon and is 
necessary for proline synthesis (1). While ProA has an initial “promiscuous” activity 
towards the substrate of ArgC, it is not physiologically sufficient to allow survival of a 
ΔargC strain of E. coli on minimal medium. The chemical transformations catalyzed by 
ProA and ArgC are identical and the substrates for ProA and ArgC differ only in the 
absence or presence of an acetyl moiety on the amino group (Fig 1.1). A spontaneous 
mutation that changes glutamate 383 to alanine in ProA (denoted hereafter as ProA*) 
allows the ΔargC strain to grow on minimal medium (21). Dr. Kershner observed that 
ΔargC E. coli grows slowly on minimal medium while using ProA* for both proline and 
arginine synthesis when compared to the wild type E. coli (Jamie et al., 2015). 
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Fig 1.1. From Jamie et al., 2015. Shows the catalytic activity of ProA and ArgC; 
substrates differ by a single acetyl moiety group.  
 
Dr. Kershner has found that after growth on minimal medium for as little as 6 
days (~25 generations), mutants that grow faster than the progenitor (E. coli ΔargC 
E383A ProA) are observed. After further investigation, mutants were found to have one 
of several genetic changes that increase fitness. These include 3 different point mutations 
(M1, M2, and M3) and various amplifications of the operon (Fig 1.2, Table 1.1). M1 and 
M2 were found within the promoter region and determined to increase overall proBA* 
transcript levels. M3, a synonymous mutation in the 3’ end of the proB coding region, 
was found to increase transcript levels of proA* without affecting transcript levels of 
proB by creating a new transcription start site in the middle of the operon (Jamie et al., 
2015). What is more surprising is that M3 mutants grow nearly as fast as cells containing 
50-fold amplifications, in which the level of transcript is markedly increased. 
Amplification strains were found to have varying 5’ ends for the amplified region, but a 
conserved 3’ end near a transposable element. Furthermore, amplification can occur in 
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∆argC proA* strains of E. coli containing M1, M2, or M3 if they are further adapted on 
minimal medium, albeit to a lesser degree (Jamie et al., 2015).  
Table 1.1. Mutations identified by Dr. Jamie Kershner after growth of a ΔargC proA* 
strain of E. coli on minimal medium. 
Mutation 
Base 
change 
Nucleotide 
Position (proBA*) Location 
M1 
g->a 
transition -30 
-35 region of the 
proBA* promoter 
M2 
c->t 
transition -10 
-10 region of the 
proBA* promoter 
M3 
a->t 
transversion 1044 3' end of proB 
 
 
Fig 1.2. From Jamie et al., 2015. A) Representation of the proBA operon in E. coli. B) 
Mutations identified by Dr. Jamie Kershner after growth of a ΔargC proA strain of E. coli 
on minimal medium. 
 
The pairwise sequence identity between the E. coli and S. enterica ProA enzymes 
is 86%. Neutral drift over time can result in sequence divergence among enzymes used to 
catalyze the same reaction that will have varying effects on the promiscuous activity of 
the enzyme (5). A study done by Khanal comparing the in vitro activity of ProA* from 9 
different microbes, including E. coli and S. enterica, shows that the initial promiscuous 
activity of ProA varies depending on the species. Furthermore, the effect of changing 
ProA to ProA* varied by species and was not correlated with the initial level of the 
M3#
!ATGGTTGGCAACCGACGACAGTCCTGCTAAAACGTT!
!
!ATGGTTGACAACCGACGACAGTCCTGCTAAAACGTT!
!
!ATGGTTGGCAACCGACGACAGTCCTGCTAAAATGTT!
!
!TTGACA # # # #TATAAT##!
!
CCGGACACCACTCGCAAGAAATTGATGCTATACTG!
!
#########################
!
!
!
!
(35# (10#
M1#
M2#
WT#
E.#coli#
consensus#
!35$ !10$
M1$ M2$ M3$
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A)#
B)#
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promiscuous activity. Khanal hypothesized that the effects of sequence divergence 
among orthologs effects not only the initial levels of promiscuous activities, but the 
evolvability of promiscuous activities as well (13). In S. enterica, the glutamate 
corresponding to E383 of the E. coli enzyme is at position 382 of the S. enterica enzyme 
(16). A ∆argC strain of S. enterica can’t grow on minimal medium because it lacks the 
ability to synthesize arginine. However, a ∆argC proA* strain of S. enterica can grow 
slowly on minimal medium by using ProA* for both proline and arginine synthesis. The 
experiments described in this thesis investigate the initial genetic changes that increase 
fitness of a ΔargC strain of Salmonella enterica subsp. enterica serovar Typhimurium 
str. SL1344 when limited by the inefficient bi-functional enzyme ProA*. In addition to 
identifying specific genetic changes, I aim to investigate how differences in the genetic 
background and physiology of the organism affect what changes are selected for and the 
adaptive potential of such changes.  
In chapter two, I sought to identify the initial genetic changes that increase fitness 
of a ΔargC strain of S. enterica whose growth rate is limited by ProA*. First, I plated this 
strain on plates containing M9/glucose and identified faster-growing colonies. Next, these 
faster-growing colonies were analyzed by qPCR to determine whether amplification of 
the proBA* operon had occurred. Mutants for which amplification of the proBA* operon 
was not detected were screened using PCR and subsequent Sanger sequencing to identify 
mutations in the proBA* operon (Macrogen). The promoter mutation, M2, was the only 
genetic change identified in faster-growing colonies of the ΔargC proA* strain of S. 
enterica after growth on minimal medium. 
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The third chapter involves taking a deeper look at why M1 and M3 were not 
found in faster-growing colonies of the ΔargC proA* strain of S. enterica after growth on 
minimal medium. First, M1, M2, and M3 were introduced into the ΔargC proA* strain of 
S. enterica. Next, growth rates were determined for each mutant of the ΔargC proA* 
strain of S. enterica in minimal media or minimal media supplemented either with 
arginine, proline, or both. Lastly, I tried to compare the data to a previously determined 
growth rates of M1, M2, and M3 mutants of the ΔargC proA* strain of E. coli in order to 
elucidate why the mutations M1 and M3 were not identified in faster-growing colonies of 
the ΔargC proA* strain of S. enterica after adaptation on minimal medium 
In the fourth chapter, I explore whether extra time for adaptation would result in 
the amplification of the proBA* operon. To do this, I adapted 4 cell lineages of the ΔargC 
proA* strain of S. enterica for ~250 generations in M9/glucose liquid medium and looked 
for increases in growth rate over time. At the end of the adaptation, genomic DNA from 
the population for each cell lineage was collected during four time points and analyzed 
using qPCR in order to check for amplification of the proBA* operon.  
The final chapter explores why amplification was not observed in faster-growing 
colonies of the ΔargC proA* strain of S. enterica after growth on minimal medium. To 
do this, I did preliminary experiments examining the effect of amplification on the 
expression of genes surrounding the proBA* operon in amplification mutants of the 
ΔargC proA* strain of E. coli. Two strains of the ΔargC strain of E. coli carrying the 
allele for ProA* with different degrees of amplification were selected. Label-free mass 
spectrometry and qPCR were used to determine if the expression of genes within the 
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amplified region increases as gene copy number increases or if homeostatic mechanisms 
will keep protein expression at a constant level.  
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Chapter 2 
Identifying genetic changes that increase fitness of a ΔargC strain of S. enterica 
whose growth rate is limited by ProA* 
 
 Dr. Jamie Kershner identified several genetic changes that improve fitness of a 
ΔargC strain of E. coli whose growth rate is limited by an inefficient bi-functional 
enzyme, E383A ProA (ProA*). I chose to work with Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344 because of its previous use in the Copley lab and the 
amount of genetic manipulation techniques designed for it. Similar to a ΔargC strain of 
E. coli, a ΔargC strain of S. enterica can’t grow on plates containing M9/glucose (no 
amino acid supplements) because it can’t synthesize arginine. The change in ProA 
(E382A) to ProA* allows slow growth of a ΔargC strain of S. enterica on minimal 
medium.  
 This chapter describes experiments directed toward identifying the initial genetic 
changes that increase fitness in a ΔargC proA strain of S. enterica whose growth rate is 
limited by the inefficient ability of ProA* to catalyze the reduction of N-acteylglutamyl 
phosphate and glutamyl phosphate (Fig 1.1). These initial changes are important 
because they effect the epistatic interactions of successive mutations thereby changing 
the possible evolutionary trajectories (13). I started by plated the ΔargC proA* strain of 
S. enterica on M9/glucose and identified faster-growing colonies. The copy number of 
proA* in 100 of these faster-growing colonies was analyzed using qPCR to determine 
whether amplification of the proBA* operon had occurred. Lastly, mutants determined to 
 14 
have no amplification were analyzed using PCR and subsequent Sanger sequencing to 
identify mutations in the proBA* operon (Macrogen). 
 
Results 
Growth of a ∆argC proA* strain of S. enterica on M9/glucose (0.2%) for ~5-6 days 
yielded faster-growing colonies 
 To begin, I streaked an aliquot of a freezer stock of the ΔargC proA* strain of S. 
enterica onto plates containing LB. Two individual colonies were used to prepare freezer 
stocks serving as genetic replicates (JK328 and JK329) for the following experiments. 
Both genetic replicates were used during these experiments and are referred to together as 
the “parental strain”. (A list of all strains used in this thesis can be found in the 
Supplemental Information (Table S.1).) I collected 100 faster-growing colonies from two 
experiments that were done at different times. In both experiments, aliquots of a freezer 
stock of JK328 and JK329 were streaked onto plates containing LB and incubated 
overnight at 37 °C. A single colony for each genetic replicate was washed with sterile 
PBS before being spread onto plates containing M9/glucose. In addition, the same 
amount of cells was spread on plates containing LB to determine the average number of 
cells spread on M9/glucose plates. The plates were incubated at 37 °C for 5-6 days or 
until faster-growing colonies were observed (Fig 2.1). The number of colonies per plate 
varied between the two experiments, as did the number of faster-growing colonies per 
plate (Table 2.1).  
 
 15 
 
Fig 2.1. Growth of the ∆argC 
proA* strain of S. enterica on 
plates containing M9/glucose for 
5-6 days at 37 °C yields faster-
growing colonies that can be 
distinguished from smaller 
colonies that do not have increased 
fitness. 
 
 
 
 
 
 
 
 
Table 2.1. Average number of colonies per plate as determined from M9/glucose or LB 
plates. Average number of faster-growing colonies perM9/glucose plate.   
A 
Ave. number of 
colonies/plate (M9 
plates) ± s.d. 
Ave. number of 
colonies/plate (LB 
plates) ± s.d. 
Ave. number of 
faster-growing 
colonies/plate (M9 
plates) ± s.d. 
JK328 223 ± 47.7 338 ± 12.5 3.53 ± 1.7 
JK329 222 ± 9.2 384 ± 25.1 4.53 ± 2.0 
 
B 
Ave. number of 
colonies/plate (M9 
plates) ± s.d. 
Ave. number of 
colonies/plate (LB 
plates) ± s.d. 
Ave. number of 
faster-growing 
colonies/plate (M9 
plates) ± s.d. 
JK328 776.6 ± 37.2 833.3 ± 28.9 2.6 ± 1.3 
JK329 1180 ± 36.8 1150 ± 50 4.87 ± 2.1 
 
qPCR reveals that none of the faster-growing colonies obtained after growth of the 
∆argC proA* strain of S. enterica on M9/glucose contains amplification of the proBA* 
operon 
 To determine whether amplification of the proBA* has occurred in faster-growing 
colonies observed after growth of the ∆argC proA* strain of S. enterica on M9/glucose, 
qPCR was done to determine the proA* copy number present in the cell lysates of faster-
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growing mutants using icdA and gyrB as internal reference genes. All of the reagents 
used for qPCR were tested for contamination before doing any experiments by running a 
PCR reaction without template and loading the product on a 2% agarose gel (data not 
shown). I designed three primer sets for each of the three target genes. (A list of all 
primers used in this thesis can be found in the Supplemental Information (Table S.2).) A 
standard curve was generated for each primer set using four 1:10 serial dilutions of 
genomic DNA from the parental strain JK328 serving as my standards. Auto-threshold 
was used when calculating primer efficiencies from the standard curve, but then manually 
maintained thereafter. Primer sets that had the highest efficiencies were used to assess 
proA* copy number of faster-growing colonies (Table 2.2). PCR reactions using each 
primer set with a lysate of the parental JK328 strain were run on a 2% agarose gel to 
check for side products or contamination. Furthermore, the products were sent for Sanger 
sequencing to make sure the sequence of the amplified products align to the expected 
target genes and not some other location in the genome (data not shown) (Macrogen).  
Table 2.2. Primer sets designed for qPCR and their efficiencies determined by the 
standard curve. proAset1, icdAset2, and gyrBset1 were used to determine proA copy 
number in cell lysates of faster-growing colonies. 
 Primer set 
Auto-
threshold 
Primer set efficiencies 
(%) 
proAset1 1.45 92.3 
proAset2 1.87 90.4 
proAset3 1.97 90.7 
icdAset1 1.19 91.3 
icdAset2 0.99 93.1 
icdAset3 2.08 92.6 
gyrBset1 1.05 96.0 
gyrBset2 2.72 91.6 
gyrBset3 2.17 91.8 
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 Cell lysates of 100 faster-growing colonies were screened with the best primer set 
for each target gene on the same plate in order to eliminate the need for inter-run 
calibrators. Cell lysates of faster-growing colonies were screened initially without 
replicates and those that showed a proA* copy number relative quantity (CNRQ) value 
greater than 1.5 or less than 0.5 were re-screened in duplicate. The first and last dilutions 
of the parental strain JK328 genomic DNA standards were used as the reference for 
determining the proA* copy number of cell lysates from faster-growing colonies. Primer 
efficiencies and average Ct values for each reaction were exported to Excel for analysis 
with qBASE (11). None of the 100 faster-growing colonies had an increase in proA* 
copy number (Fig 2.2).  
 
Fig 2.2. A histogram and box plot showing proA* CNRQ values for 100 faster-growing 
colonies determined by qPCR of cell lysates. 
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All of the faster-growing colonies obtained after growth of the ∆argC proA* strain of S. 
enterica on M9/glucose contain the promoter mutation M2 
 I sequenced the proBA* operon using genomic DNA prepared from faster-
growing colonies collected from M9/glucose plates containing the S. enterica parental  
strain. Two primer sets were designed to amplify the upstream and downstream segments 
of the operon with a ~500 bp overlap. These segments were PCR-amplified from the cell 
lysates of faster-growing colonies as well as the parental JK328 strain. The amplified 
PCR product using the cell lysate of my parental JK328 strain was run on a 2% agarose 
gel with a DNA ladder to assess the size of the amplified fragment and to check for side 
products that could interfere with Sanger sequencing (Fig 2.3). Sanger sequencing of the 
PCR-amplified products from cell lysates of faster-growing colonies was done to identify 
any mutations within the proBA* operon (Macrogen). I sequenced the entire proBA* 
operon for 20 of the 100 faster-growing colonies; only M2 in the promoter was found. 
For an additional 30 large colonies, only the promoter region was sequenced in order to 
reduce the cost of sequencing. In total, 50 out of 100 faster-growing colonies were 
determined to have M2.  
 
Fig 2.3. Visualization of PCR-amplified 
segments of the proBA* operon from cell 
lysate of the parental strain (JK328) to 
check their size with a 1 kb plus DNA 
ladder (Invitrogen, lane 1). The 3’ 
downstream segment (lane 2) was PCR-
amplified with primers JC-P2 and JC-P3 
and has an expected size of 1762 bp. The 5’ 
upstream segment (lane 3) was PCR-
amplified with primers JC-P25 and JC-P25 
and has an expected size of 1657 bp.  
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Discussion 
 In this chapter, I have discussed the identification of genetic changes that increase 
fitness in a ΔargC proA* strain of S. enterica whose growth rate is limited by the 
inefficiency of ProA*. These findings suggest that amplification does not occur after 
adaptation of ΔargC proA* S. enterica strain on M9/glucose. This is interesting 
considering that various extents of amplification are observed after adaptation of the 
ΔargC proA* E. coli strain on M9/glucose (Jamie et al., 2015).  On the one hand, it could 
be that amplification of proBA* and the surrounding regions has a more detrimental 
fitness impact in S. enterica than in E. coli (8). This seems plausible given the differences 
in genetic context downstream of the proBA operon, but can’t be concluded based on 
these results (Fig 2.4). Alternatively, It may be that the absence of an IS5 transposable 
element in S. enterica that is consistently observed at the 3’ end of the amplified region in 
E. coli is making amplification of the region less frequent (Jamie et al., 2015). In either 
case, point mutations that do increase fitness do not prevent amplification from occurring 
at a later time point if fitness can still be improved (18). Experiments in the following 
chapters attempt to address these questions. 
 
Fig 2.4. Map of the amplified regions identified in E. coli mutants. Top bar is a 
representation of the genome with colored boxes indicating genes. Red: proBA operon, 
Blue: genes found in both E. coli and S. enterica, Grey: genes found only in E. coli. 
Black bars indicate the region amplified in three different mutants (A1, A2 and A3). All 
amplifications identified in E. coli have the same 3’ end, which is not present in S. 
enterica. 
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 In the 50 faster-growing colonies I screened, only M2 was observed. M2 is a 
promoter mutation that was determined to increase the overall transcript levels of proBA* 
in E. coli. The absence of M1 and M3 in faster-growing colonies may be due to a low 
frequency of these mutations, or a low impact of these mutations on fitness. Depending 
on the frequency of these mutations, screening enough faster-growing colonies to find 
these mutations could be costly and time consuming. The use of genomic editing to 
create these mutations will be used to assess their fitness effects in Chapter 3.  
 
Methods 
S. enterica ΔargC E382A ProA strain (parental strain) 
 Salmonella enterica subsp. enterica serovar Typhimurium str. SL1344 was 
obtained from the Keio collection. S. enterica is a histidine auxotroph, Dr. Juhan Kim 
used the pSLTS method to fix a nonsense mutation in hisG, a gene required for the 
production of histidine. Furthermore, he used this method to knockout argC and change 
glutamate 382 to alanine in ProA (14). S. enterica has a natural resistance to streptomycin 
(strep), which was supplemented in the medium periodically to select against other 
bacterial species. 
Plating the parental ΔargC proA* strain of S. enterica on M9/glucose and collecting 
faster-growing colonies 
 An aliquot of a freezer stock of the parental ΔargC proA* strain of S. enterica 
was streaked onto plated containing LB/strep (50 μg/mL) and incubated at 37 °C 
overnight. Two individual colonies serving as genetic replicates (JK328 and JK329) were 
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washed twice with 100 µL sterile PBS, suspended in 100 µL sterile PBS, and diluted 
1:10000 (D1) for subsequent plating. Two µL of each suspension were used to inoculate 
1 mL LB/strep (50 μg/mL) and grown at 37 °C until mid-log to make freezer stocks (10% 
DMSO (v/v)). 
 Fifteen, 50 µL aliquots of dilution D1 for each parental strain were spread on 
plates containing M9/glucose (0.2%)/strep (50 μg/mL) using sterile glass beads for a total 
of 30 plates. Plates were incubated at 37 °C for 5-6 days or until faster-growing colonies 
are observed. Three, 50 µL aliquots of dilution D1 for each parental strain were also 
spread on plates containing LB/strep (50 μg/mL) using sterile glass beads to evaluate the 
amount of cells spread on the M9/glucose plates.   
 After incubation of the M9/glucose plates at 37 °C for 5-6 days, 25 faster-growing 
colonies from each genetic replicate (JK328 and JK329) were each suspended in 20 µL 
sterile H2O, streaked onto plates containing M9/glucose (0.2%)/strep (50 μg/mL), and 
incubated overnight at 37 °C. The remainder of each suspension was boiled at 98 °C for 
10 min, diluted with 40 µL sterile H2O, and stored at -20 °C for copy number 
determination by qPCR or Sanger sequencing.  
Four sub-clones from each isolation streak were suspended in 20 µL sterile H2O 
(200 total). Two µL from each suspension were used to inoculate 0.5mL M9/glucose 
(0.2%)/strep (50 μg/mL) liquid media which was incubated overnight at 37 °C with 
shaking until mid-log and used to make freezer stocks (DMSO 10% (v/v)). The 
remainder of each suspension was boiled at 98 °C for 10 min, diluted with 40 µL sterile 
H2O, and stored at -20 °C for copy number determination via qPCR or Sanger 
sequencing. 
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Designing primer sets for qPCR, making the standard curve, and determining proA 
CNRQ values from cell lysates of faster-growing colonies 
 Primer3Plus (Bioinformatics) was used to design primers that anneal to proA, 
icdA, and gyrB of S. enterica and can be used to amplify 50-150 bp fragments using PCR. 
NCBI was used to obtain the target sequences for this strain. Settings used were: Na+, 50 
mM; Mg++, 1.5 mM; dNTPs, 0.6 mM; target type, DNA; and oligo concentration, 0.25 
μM. mFold was used to estimate the ΔG of secondary structures in the amplified product 
that could interfere with accurate primer efficiencies, especially when secondary 
structures block where your primers bind. Settings were the same as those for 
Primer3Plus. IDT Oligo-analyzer was used to estimate the ΔG of self/hetero primer 
dimerization to assure that the primers would not anneal to each other and produce faulty 
primer efficiencies. Three primer sets for each of the target genes were made in order to 
increase the chance of getting a good primer set.  
The genes icdA and gyrB, assumed to be present as a single copy in the genome, 
were used as internal reference genes for qPCR estimation of the copy number of proA. 
Cycling conditions for a standard run with Power SYBR Green in a 7500 Fast Real-Time 
PCR system (Applied Biosystems) were as follows: 95 °C for 10 min; 40 cycles of 95 °C 
for 15 s, 60 °C for 60 s. A melt curve was performed immediately following qPCR in 
order to test for multiple products or contamination of the samples.  
A standard curve was generated for each primer set using four 1:10 serial 
dilutions of genomic DNA from the parental strain JK328 serving as my standards. Two 
µL of each parental strain (JK328) genomic DNA dilution were used in triplicate with 0.4 
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µL each of the 10 µM forward and reverse primers, 7.2 µL sterile H2O, and 10 µL 2X 
SYBR Green master mix (Applied Biosystems). Reactions mixtures without template for 
each primer set were included during each run in order to check for contamination. Auto-
threshold, cycling conditions, annealing temp, and auto-baseline settings were not 
changed when determining primer efficiencies from the standard curve. However, 
thresholds determined for a primer set during the standard curve experiment were used 
for further experiments using those primers. The Primer sets with the highest efficiency 
determined using the 7500 Software v2.3 were selected for mutant screening (Table 2.2).  
Faster-growing colonies were screened with the best primer set for each target 
gene on the same plate in order to eliminate the need for inter-run calibrators. Reaction 
mixtures contained 2 µL template, 0.4 µL each of the 10 µM forward and reverse 
primers, 7.2 µL sterile H2O, and 10 µL 2X SYBR Green master mix (Applied 
Biosystems). The first and last dilutions of the parental strain JK328 genomic DNA 
standards were used as the reference for determining the CNRQ of proA* of faster-
growing colonies. The average efficiencies for each primer set and the average Ct values 
for each reaction were exported into Excel for analysis with qBase in order to generate 
the copy number relative quantity (CNRQ) of proA* for each mutant (11). Mutants were 
screened initially without replicates, and those that showed a CNRQ value greater than 
1.5 or less than 0.5 were re-screened in duplicate. For mutants with confirmed copy 
number increase, sub-clones were used to prep genomic DNA and screened in triplicate 
to get a more accurate CNRQ for proA*.  
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Identification of mutations in the proBA* operon of faster-growing colonies using Sanger 
sequencing 
 Primers were designed to amplify two fragments that have an ~500 bp overlap 
and cover the entire proBA operon and its regulatory regions (~3 kb). Aliquots of freezer 
stocks for sub-clones prepped from mutants were streaked onto plates containing 
LB/strep (50 μg/mL) and incubated overnight at 37 °C. Single colonies were suspended 
in 50 µL sterile H2O, boiled at 98 °C for 10 min, and stored at -20 °C prior to PCR 
amplification. Two µL of the mutant cell lysate were used in a 30 µL PCR reaction with 
15 µL OneTaq HS 2X master mix, 0.6 µL of each 10 µM forward and reverse primers, 
and 11.8 µL sterile H2O. Three µL of each PCR product was run on a 2% agarose gel in 
order to assess the size with a 1 kb plus DNA ladder (GeneRuler).  The remainder of the 
PCR products were loaded and run on a 2% agarose gel for extraction using a GeneJET 
Gel Extraction Kit or simply purified using a GeneJET PCR Purification Kit 
(ThermoScientific) and eluted in 30 µL EB. Lastly, 100-200 ng of the eluted DNA was 
sent with each primer that was used to amplify it for Sanger sequencing (Macrogen). 
Preparation of M9/glucose (0.2%) plates (1 L = 40 plates) 
In 0.989 L deionized-H2O, add and autoclave M9 salts 
 6.78 g Na2HPO4 
 3 g KH2PO4 
 1 g NH4Cl 
 0.5 g NaCl 
 
Add the following after sterilization 
 10 mL 20% glucose 
 1 mL 1 M MgSO4 
 100 μL 1 M CaCl2 
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Chapter 3 
Analysis of the effect of M1, M2 and M3 on growth rate of  
  the ∆argC proA* strain of S. enterica 
 
 All of the faster-growing colonies obtained after growth of the ∆argC proA* 
strain of S. enterica on M9/glucose contain the promoter mutation M2. This finding is in 
contrast to the identification of 3 different point mutations (M1, M2, and M3) in faster-
growing colonies obtained after growth of the ΔargC proA* strain of E. coli on 
M9/glucose. The first two mutations, M1 and M2, occur in the promoter region of the 
proBA operon and were determined to increase fitness in the E. coli parent strain by 
increasing overall transcript levels of the proBA operon  (Jamie et al., 2015). The third 
mutation, M3, is a synonymous mutation at the 3’ end of proB that was determined by 
RT-qPCR to increase transcript levels of only proA by creating a second promoter (Jamie 
et al., 2015). Synonymous mutations are implicated in adaptation and evolution by 
changing translation efficiency, creating new mRNA secondary structures, and affecting 
regulation of transcription (2, 6, 7). This chapter describes the introduction of comparable 
mutations into the genome of the ∆argC proA* strain of S. enterica and assessment of 
their effects on growth rate to determine whether their absence in faster-growing colonies 
is due to a low frequency of these mutations, or a low impact of these mutations on 
fitness. In addition, M2 was inserted back into a ΔargC proA* strain of S. enterica to test 
the fitness impact of this mutation in the absence of other mutations possibly acquired 
during growth on M9/glucose. 
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 The pSLTS method for scarless genome editing by Dr. Juhan Kim was used to 
introduce these mutations back into a ΔargC proA* strain of S. enterica. First, mutation 
template plasmids were made for each mutation (M1, M2, and M3) using Gibson 
assembly and were used to transform chemically competent E. coli MACH1 cells (Fig 
3.1, A). These cells were cultured and harvested to obtain the mutation template plasmid. 
The mutation cassettes were amplified from harvested mutation template plasmids using 
PCR (Fig 3.1, B). Cells of the ΔargC proA* strain of S. enterica containing the pSLTS 
plasmid were cultured in media containing arabinose to induce expression of λ-red 
recombinases necessary for mutation cassette transformation (Fig 3.1, C). Once cells 
were transformed with the mutation cassette and selected for having the selection marker, 
they were plated on anhydrotetracycline to remove the selection marker and restore the 
correct ORF of the gene with the intended mutation (Fig 3.1, D). A growth curve was 
generated for each clone in M9/glucose and M9/glucose supplemented either with 
proline, arginine, or both. 
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A)    B) 
 
C)         D) 
 
 
 
Fig 3.1. From Kim, 2014. Diagrams the pSLTS method developed by Dr. Juhan Kim to 
do scarless genome editing of the S. enterica genome that I used to introduce M1, M2 and 
M3 into the ΔargC proA* strain of S. enterica. A) Construction of the mutation template 
plasmid B) amplification of the mutation cassette C) Introduction of the mutation cassette 
D) removal of the selection marker.  
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Results 
Introduction of M1, M2 and M3 into the ΔargC proA* strain of S. enterica 
 The upstream and downstream fragments for the M2 mutation template plasmid 
were amplified by PCR from a ΔargC proA* strain of S. enterica containing M2 (JC67) 
using primers designed to add overhangs overlapping the selection marker and pUC19 
backbone (Fig 3.2). These overhangs are necessary for Gibson assembly of the M2 
mutation template plasmid. The PCR products containing the amplified upstream and 
downstream fragments were run on a 2% agarose gel in order to assess their size with a 
DNA ladder (Fig 3.3). gBLOCKs of the upstream and downstream fragments for the M1 
and M3 mutation template plasmids were ordered from IDT. The Gibson assembly 
master mix was used to assemble each mutation template plasmid from the corresponding 
upstream and downstream fragments, a linear pUC19 backbone, and the CAT selection 
marker (NEB). The pUC19 backbone contains a gene for ampicillin (amp) resistance and 
the CAT selection marker contains a gene for chloramphenicol (chl) resistance. 
Chemically competent E. coli Mach1 cells obtained from Dr. Juhan Kim were 
transformed with the mutation template plasmid using the heat-shock method (NEB). 
Overnight growth on plates containing LB with ampicillin and chloramphenicol selects 
against cells that have not taken up the mutation template plasmid. Cells that were 
successfully transformed with the mutation cassette plasmid observed for each mutation 
template plasmid (Fig 3.4). 
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Fig 3.2. Primers were designed to amplify the upstream and downstream fragments using 
PCR from a ΔargC proA* strain of S. enterica containing M2 (JC67) and add overhangs 
that overlap the selection marker and pUC19 backbone necessary for Gibson assembly of 
the M2 mutation template plasmid (NEB). 
 
Fig 3.3. Visualization of PCR-amplified 
segments of the proBA* operon from cell 
lysate of a ΔargC proA* strain of S. enterica 
containing M2 (JC67) to check their size with 
a kb plus DNA ladder (Invitrogen, lane 1). The 
upstream fragment (lane 2) was PCR-
amplified with primers JC-P37 and JC-P38 
and has an expected size of 228 bp; a no 
template control was done for this reaction 
(lane 3). The downstream fragment (lane 4) 
was PCR-amplified with primers JC-P39 and 
JC-P40 and has an expected size of 227 bp; a 
no template control was done for this reaction 
(lane 5). 
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Fig 3.4. Overnight growth of E. coli MACH1 cells on plates containing LB, amp (100 
µg/mL) and chl (20 µg/mL) after transformation with the mutation template plasmid 
using the heat-shock method (NEB). From left to right: M1, M2, and M3. 
 
 Primers that anneal to the pUC19 backbone of the mutation template plasmid and 
flank the mutation cassette were used to screen the cell lysate of colonies that survived 
overnight growth on LB/amp/chl for the correct assembly. The size of the amplified 
fragment was assessed on a 2% agarose gel using electrophoresis with a DNA ladder 
prior to sending it for Sanger sequencing (Fig 3.5). One colony from each mutation 
template plasmid transformation (M1, M2, and M3) that was confirmed to have the 
correct assembly was labeled and used to prepare freezer stocks: JC518 for M1, JC546 
for M2, and JC519 for M3.  
   
Fig 3.5. Visualization of PCR-amplified segments containing the mutation cassette from 
cell lysates of E. coli MACH1 colonies that survived overnight growth on plates 
containing LB/amp/chl after to assess their size with a 1 kb plus DNA ladder from either  
(Invitrogen, lane12) or (Gene ruler, lane 1 and 19). The segment was PCR-amplified with 
primers pH.seq.F and pH.seq.R and has an expected size of 1757 bp for M1 (lanes 2-5), 
1723 bp for M2 (lanes 6-11 and 13-18), and 1757 bp for M3 (lanes 20-22).  
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 Primers were designed to amplify the mutation cassettes from the mutant template 
plasmids using PCR. JC518, JC546, and JC519 cells containing the M1, M2, and M3 
mutation template plasmids respectively were cultured in LB media containing amp and 
chl and harvested to obtain a large quantity of each mutation template plasmid. Primers 
designed to amplify each mutation cassette were used in a PCR reaction with the 
corresponding mutation template plasmid. The sizes of the amplified mutation cassettes 
were assessed by electrophoresis on a 2% agarose with a DNA ladder (Fig 3.6).  
  
Fig 3.6. The PCR-amplified mutation cassettes were run on a 2% agarose gel to assess 
their size with a 1 kb plus DNA ladder (Invitrogen, lanes 1, 3 and 5). The M1 mutation 
cassette (lane 2) was PCR-amplified with primers JC-P29 and JC-P30 and has an 
expected size of 1289 bp. The M2 mutation cassette (lane 4) was PCR-amplified with 
primers JC-P41 and JC-P42 and has an expected size of 1305 bp. The M3 mutation 
cassette (lane 6) was PCR-amplified with primers JC-P31 and JC-P32 and has an 
expected size of 1306 bp. 
 
 Cells of a ΔargC proA* strain of S. enterica containing the pSLTS plasmid were 
cultured in LB media containing arabinose to induce expression of λ-red recombinases 
from genes present on the pSLTS plasmid. The pSLTS plasmid contains a gene for 
ampicillin resistance and has a temperature sensitive origin of replication that allows 
replication of the plasmid at a temperature of 30 °C, but not at 37 °C. I mixed each 
mutation cassette with electrocompetent cells of a ΔargC proA* strain of S. enterica 
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+pSLTS (JC517) that were expressing λ-red recombinase and transformed them using 
electroporation. Cells were spread on plates containing LB/amp/chl and grown overnight 
at 30 °C to select for those that have integrated the mutation cassette containing the 
selection marker with a gene for chloramphenicol resistance (Fig 3.7). Up to four 
colonies from mutation cassette transformation were transferred onto fresh plates 
containing LB/amp/chl and incubated overnight at 30 °C to remove background colonies.  
A)       B) 
 
C) 
  
Fig 3.7. Overnight growth of JC517 cells on plates containing LB, amp (100 µg/mL) and 
chl (20 µg/mL) after transformation with the mutation cassette using electroporation 
(NEB). A) JC517 cells transformed with the M1 mutation cassette. B) JC517 cells 
transformed with the M2 mutation cassette. C) JC517 cells transformed with the M3 
mutation cassette. 
 
 A single colony from each isolation streak was suspended in sterile PBS and 
spread onto plates containing LB/amp or LB/amp with anhydrotetracycline (atc). In 
addition, these suspensions were used to inoculate 2mL LB/amp/chl liquid medium. The 
cultures were incubated at 30 °C and used to make freezer stocks; JC520-JC522, M1 
mutation cassette transformant; JC551, and JC554-JC556, M2 mutation cassette 
transformant; JC523-JC526, M3 mutation cassette transformant. Anhydrotetracycline 
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allows expression of the I-Sce1 meganuclease encoded on the pSLTS plasmid. The 
meganuclease will cut at a site within the selection marker, forcing the double-strand 
DNA repair mechanism to use homologous regions on the upstream and downstream 
fragments (HR3) to repair the damage thereby eliminating the selection marker in the 
process (Fig 3.1). The reduction in the number of colonies on plates containing LB/atc 
suggests that the expected double-strand breakage occurred (Fig 3.8). Five colonies from 
each plate containing LB/atc were patched onto plates containing either LB/amp or 
LB/amp/chl. Colonies that can’t survive on plates containing LB/amp/chl have lost the 
selection marker restoring the complete and correct ORF of the proA* (Fig 3.9).  
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A) JC520, JC521, and JC522. Left: LB/ amp; right: LB/ amp/ atc. 
 
 
B) JC551, JC554, JC555, and JC556. Left: LB/ amp/ atc; right: LB/ amp. 
 
C) JC523, JC524, JC525, and JC526. Left: LB/ amp; right: LB/ amp/ atc. 
 
 
Fig 3.8. Overnight growth of isolated JC517 transformants with mutation cassette inserts 
on plates containing Lb with either amp (100 µg/mL) or amp (100 µg/mL) and atc (100 
ng/mL). A) JC517 isolates with M1 mutation cassette insert. B) JC517 isolates with M2 
mutation cassette insert. C) JC517 isolates with M3 mutation cassette insert.  
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A) quadrants 1-5, JC520; quadrants 6-10, JC521; quadrants 11-15, JC522. Left: LB/ amp; 
right: LB/ amp/ chl. 
 
B) quadrants 1-5, JC551; quadrants 6-10, JC554; quadrants 11-15, JC555; quadrants 16-
20, JC556. Left: LB/ amp/ chl; right: LB/ amp. 
 
C) quadrants 1-5, JC523; quadrants 6-10, JC524; quadrants 11-15, JC525; quadrants 16-
20, JC526. Left: LB/ amp; right: LB/ amp/ chl. 
 
Fig 3.9. Overnight growth of individual colonies patched onto plates containing LB with 
either amp (100 µg/mL) or amp (100 µg/mL) and chl (20 µg/mL) that were taken from 
LB/amp/atc plates containing overnight growth of JC517 isolates transformed with the 
mutation cassettes (Fig 3.8). Cells that can’t survive on plates containing chl have lost the 
selection marker that contains the gene for chl resistance. A) Colonies patched from 
LB/amp/atc plates containing overnight growth of JC517 isolates with M1 mutation 
cassette insert. B) Colonies patched from LB/amp/atc plates containing overnight growth 
of JC517 isolates with M2 mutation cassette insert. C) Colonies patched from 
LB/amp/atc plates containing overnight growth of JC517 isolates with M3 mutation 
cassette insert 
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 PCR and subsequent Sanger sequencing was done using primers that flank the 
area where the mutation cassette was expected to integrate to screen colonies that could 
survive on LB/amp but not LB/amp/chl. The product of this PCR reaction was visualized 
on a 2% agarose gel with a DNA ladder to assess the size of the amplified fragment prior 
to sending it for Sanger sequencing (Fig 3.10). Colonies that were confirmed to have the 
intended mutation were labeled and used to make freezer stocks; JC543, M1; JC559 and 
JC560, M2; JC544 and JC545, M3.  
 
A)                                                                         
B)   
     
Fig 3.10. PCR-amplified segments of the proBA* operon from cell lysate of colonies on 
patch plates were run on a 2% agarose gel with either a 1 kb plus DNA ladder 
(Invitrogen, lane 9) or a 100 bp DNA ladder (Invitrogen, lanes 1, 12 and 22) to assess 
their size prior to Sanger sequencing. A) The proBA* operon was PCR-amplified from 
M1 utants (lanes 2-7) and M2 mutants (lanes 10 and 11) using primers JC-P33 and JC-
P34 with an expected size of 1091 bp; positive control was done using JK328 cell lysate 
(lane 8). B) The proBA* operon was PCR-amplified from M3 mutants (lanes 13-20) 
using primers JC-P35 and JC-P36 with an expected size of 972 bp; positive control was 
done using JK328 cell lysate (lane 21). 
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 Point mutations M1, M2, and M3 increase the growth rate of the ∆argC proA* S. 
enterica strain on M9/glucose 
 In order to test the effect M1, M2, and M3 have on the growth rate of my S. 
enterica parent strain, all three clones were tested along with the parent strain (JK328) 
and WT (JK411) strain. The growth curve was done using a single biological replicate in 
triplicate for each strain in each growth condition. The growth conditions used were 
M9/glucose (0.2%), M9/glucose +0.4 mM proline, M9/glucose +5.2 mM arginine, and 
M9/glucose +0.4 mM proline and 5.2 mM arginine. The mean specific growth rate (λ) for 
each strain in each condition was estimated by non-linear regression using the modified 
Gompertz equation (24). The results from this experiment show that M1, M2, and M3 all 
increase the growth rate of the ∆argC proA* strain on M9/glucose (Fig 3.11). 
Furthermore, cells of all strains except for those of the wild type version of S. enterica 
were more limited in their ability to synthesize arginine than proline. The growth rate of 
all strains was similar to the wild type version of S. enterica when grown on M9/glucose 
supplemented with both arginine and proline. 
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Fig 3.11. The mean specific growth rate (λ) of S. enterica strains in M9/glucose (0.2%), 
M9/glucose +0.4 mM proline, M9/glucose +5.2 mM arginine, and M9/glucose +0.4 mM 
proline and 5.2 mM arginine. Blue bars represent the mean specific growth rate of the 
wild type S. enterica (JK411) in the indicated medium. Red bars represent the mean 
specific growth rate of the ∆argC proA* parental strain of S. enterica (JK328) in the 
indicated medium. Green, purple, and orange bars represent the mean specific growth 
rate of ∆argC proA* S. enterica clones containing mutations M1, M2, and M3 
respectively in the indicated medium. This was done using 1 biological replicate in 
triplicate. Error bars represent one s.d. from the mean.    
 
Discussion 
 Both promoter mutations, M1 and M2, increased the specific growth rate of the 
∆argC proA* strain of S. enterica under all conditions tested (Fig 3.11). Furthermore, M1 
seems to be more beneficial than M2, even though it was never observed in faster-
growing colonies after growth of the ∆argC proA* strain of S. enterica on M9/glucose. 
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The synonymous mutation M3 also increased growth rate, albeit very low. In order to be 
confident that this difference in growth rate is significant, I need more biological 
replicates. However, these data does suggest that its absence in faster-growing colonies 
after growth of the ∆argC proA* strain of S. enterica on M9/glucose is due to a lack of its 
fitness impact rather than a lack of adequate sample size; a slight increases in growth rate 
will not be caught by eye.   
 The mean specific growth rate of all strains except for wild type S. enterica was 
lower when cells were grown in M9/glucose supplemented with proline compared to 
arginine (Fig3.11). These results suggest that the ∆argC proA* strain of S. enterica is 
more limited in its ability to use ProA* for arginine synthesis than for proline synthesis. 
However, it is strange that the growth rates for all strain in M9/glucose supplemented 
with proline matches their growth rates in just M9/glucose. In the future, I will analyze 
more biological replicates in order to test if these results are reproducible and to account 
for biological variability. Furthermore, I will want to compare my results to those found 
in similar experiments involving the ∆argC proA* strain E. coli. This will allow me to 
compare the fitness impact of M1, M2, and M3 in ∆argC strains of E. coli and S. enterica 
whose growth rates are limited by the ability to use a similar inefficient bi-functional 
enzyme (ProA*) for both proline and arginine synthesis.  
 
Methods 
Assembling the M1, M2, and M3 mutation template plasmids and PCR amplification of 
the mutation cassettes 
 A gBLOCK of the upstream and downstream fragments for the M1 and M3 
mutation template plasmid was ordered from IDT. The upstream and downstream 
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fragments for the M2 mutation template plasmid were amplified from a ∆argcC proA* 
strain of S. enterica containing M2 (JC67) using primers that add overhangs overlapping 
the CAT selection marker and pUC19 backbone. To do this, an aliquot of a freezer stock 
of JC67 was streaked onto plates containing LB/ strep (50 μg/mL) and incubated 
overnight at 37 °C. A single colony was suspended in 50 µL sterile H2O and 2 µL of the 
suspension were used in a 100 µL PCR reaction with 50 µL OneTaq HS 2x MM, 2 µL of 
each 10 µM forward and reverse primers, and 44 µL sterile H2O. Three µL of each PCR 
reaction mixttures were run on a gel in order to assess the size with a 1 kb plus DNA 
ladder (Invitrogen). The remaining PCR reaction mixtures were treated with an overnight 
dpn-1 digest, run on a 2% agarose gel, and extracted using the GeneJET Gel Extraction 
Kit (ThermoScientific) to remove any template still present that could interfere with 
Gibson assembly of the mutation template plasmid.  
  Gibson assembly of the three mutation template plasmids was done using the 
Gibson assembly 2x mastermix (NEB). The product of my Gibson assembly reactions 
were subsequently used to transform chemical competent E. coli Mach1 cells using the 
heat shock method (NEB). To do this, ~50ng of the mutation cassette is added to an 
aliquot of chemical competent E. coli Mach1 cells and incubated on ice for 30 minutes. 
Then, the tube containing the cells is submerged in a hot-water bath set to 42 °C for 
exactly 30 seconds before being placed back on the ice for another 5 minutes. Cells were 
allowed to recover in 1 mL SOC recovery broth for 1 hour at 37 °C with shacking. 
Lastly, cell were spread on plates containing LB/amp (100 μg/mL)/chl (20 μg/mL) and 
incubated overnight at 37 °C to select for those that have taken up the mutation template 
plasmid.  
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 Primers that anneal to the pUC19 backbone of the mutation template plasmid and 
flank the region containing the mutation cassette were used to screen E. coli Mach1 cells 
that survived overnight growth on plates containing LB/amp (100 μg/mL)/chl (20 
μg/mL). To do this, individual colonies were suspended in 50 µL sterile H2O. Then, 2 µL 
of the suspension were used in a 30 µL PCR reaction with 15 µL OneTaq HS 2x MM, 0.6 
µL of each 10 µM forward and reverse primers, and 11.8 µL sterile H2O. The product of 
each PCR reaction was run on a gel in order to assess the size with a 1 kb plus DNA 
ladder (Invitrogen) before sending it for Sanger sequencing (Macrogen). Colony 
suspensions were stored at 4 °C until sequencing results confirming the correct assembly 
were received. A single colony suspension containing E. coli Mach1 cells determined to 
have the correct assembly for each mutation template plasmid transformation was used to 
inoculate 2 mL LB/amp (100 μg/mL)/chl (20 μg/mL) liquid medium, incubated at 37 °C 
overnight, and harvested for plasmid prep (Qiagen). In addition, this suspension was also 
used to inoculate 1 mL LB/amp (100 μg/mL)/chl (20 μg/mL) liquid medium, incubated at 
37 °C until mid-log, and used to prepare freezer stocks (10% DMSO (v/v)). 
 Primers were designed to amplify mutation cassettes from the mutant template 
plasmids using PCR. First, 2 µL of the eluted plasmid were used in a 100 µL PCR 
reaction with 50 µL OneTaq HS 2x MM, 2 µL of each 10 µM forward and reverse 
primers, and 44 µL sterile H2O. The product of each PCR reaction was run on a gel in 
order to assess the size with a 1 kb plus DNA ladder (Invitrogen). The amplified mutation 
cassettes were then treated with an overnight dpn-1 digest, run on a 2% agarose gel, and 
extracted using the GeneJET Gel Extraction Kit (ThermoScientific) to remove template 
still present in the PCR reaction mixtures.  
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Transformation of a ∆argC proA* strain of S. enterica with the mutation cassette and 
removal of the selection marker 
 A ΔargC E383A ProA strain of S. enterica with the pSLTS plasmid already 
introduced was obtained from Dr. Juhan Kim. An aliquot of the freezer stock was used to 
inoculate 2 mL LB/amp (100 µg/mL), grown until mid-log at 30 °C, and used to make a 
freezer stock of my own (10% DMSO (v/v)). An aliquot of the freezer stock was streaked 
onto plates containing LB/amp (100 μg/mL) and incubated overnight at 30 °C with 
shaking. A single colony was used to inoculate 5 mL LB/amp (100 μg/mL) and incubated 
at 30 °C with shaking. At mid-log, 1 mL of the culture was used to inoculate a 100 mL 
LB/amp (100 μg/mL) and incubated at 30 °C. After 1 hour, L-arabinose was added to a 
final concentration of 2 mM and incubated for ~4 hours until the culture reached an 
OD600 of .95. Twice the recommended amount of arabinose and a longer growth period 
after the addition of L-arabinose is needed when working with S. enterica. Two 50 mL 
aliquots of the culture were harvested via centrifugation at 4,500 xg for 10 min at 4 °C 
and washed with 25 mL ice-cold 10% glycerol via vortex. Aliquots were combined, 
harvested again via centrifugation, and wash with 25 mL ice-cold 10% glycerol via 
vortex. This was done once more with 12.5 mL ice-cold 10% glycerol before suspending 
the cell pellet in ~500 µL residual glycerol. Aliquots of the suspended cells were used 
immediately to introduce the mutation cassette; electrocompetent S. enterica cells do not 
work well when stored for later use. 
 The eluted mutation cassettes for M1, M2, and M3 were quantified using Qubit 
dsDNA BR. For each mutation cassette, about 50 µg of the eluted cassette was added to 
the E-comp cells prepared as described in the last section. Cells were transformed by 
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electroporation, suspended in 1 mL SOC recovery broth, and incubated for ~5 hours at 30 
°C. Cells were spread onto plates containing LB/amp (100 μg/mL)/chl (20 μg/mL) and 
incubated at 30 °C overnight. Up to Four individual colonies were isolation streaked onto 
fresh plates containing LB/amp (100 μg/mL)/chl (20 μg/mL) and incubated at 30 °C 
overnight in order to remove background growth. A single colony from each of the 4 
isolation streaks was suspended in 500 µl sterile PBS; 100 µL was spread onto plates 
containing LB/amp (100 μg/mL)/atc (100 ng/mL) and LB/amp (100 μg/mL) using sterile 
glass beads. Two µl of the PBS suspension were used to inoculate 2 mL LB/amp (100 
μg/mL)/chl (20 μg/mL), incubated at 30 °C until mid-log, and used to make freezer 
stocks (10% DMSO (v/v)). Five Colonies from each of the plates containing LB/amp 
(100 μg/mL)/atc (100 ng/mL) were patched onto plates containing LB/amp (100 μg/mL) 
or LB/amp (100 μg/mL)/chl (20 μg/mL) and incubated at 30 °C overnight. Colonies that 
were able to grow on plates containing LB/amp (100 µg/mL), but not LB/amp (100 
μg/mL)/chl (20 μg/mL) were picked from the LB/amp (100 μg/mL) patch plate and 
suspended in 50 µL sterile H2O.  
 PCR and subsequent Sanger sequencing of the amplified fragment was done using 
primers that flank the area where the mutation cassette was introduced to screen colonies 
that could not survive on plates containing LB/amp/chl for a loss of the selection marker 
and the desired recombination. Two µL of the cell suspension (from the last section) were 
used in a 30 µL PCR reaction with 15 µL OneTaq HS 2x MM, 0.6 µL of each 10 µM 
forward and reverse primers, and 11.8 µL sterile H2O for both primer sets. Three µL of 
each PCR reaction were run on a 2% agarose gel in order to assess the size of the 
amplified fragment with a DNA ladder. The remainder of the PCR reactions were run on 
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a 2% agarose gel and extracted using the GeneJET Gel Extraction Kit or simply purified 
using the GeneJET PCR Purification kit (ThermoScientific) and eluted in 30 µL EB. 
Then, 100-200 ng of the eluted DNA was sent with each primer that was used to amplify 
it for Sanger sequencing (Macrogen). The remaining cell suspensions were stored at 4 °C 
until the sequencing results were returned. Once one colony was confirmed by Sanger 
sequencing to have the correct mutation inserted, the cell suspension was used to 
inoculate 2 mL LB/strep (50 μg/mL), incubated at 37 °C (to removed pSLTS plasmid) 
until mid-log, and used to make freezer stock (10% DMSO (v/v)).  
Setting up the growth curve experiment and analyzing the data 
 The Growth curve for this experiment was run on a Varioskan (Thermo) plate 
reader using the SkanIt software version 2.2. Aliquots of freezer stocks were streaked 
onto M9/glucose plates and grown overnight at 37 °C. Single colonies were used to 
inoculate 2 mL LB and grown to early log-phase at 37 °C. Cultures were harvest via 
centrifugation at 4,500 xg for 8 min at room temperature, washed twice with 500 µL 
sterile PBS, and re-suspended in 500 µL sterile PBS. The cells were diluted to an OD600 
of 0.01 in M9/glucose and 10 µl aliquots were used to inoculate their corresponding wells 
containing 90 µL M9/glucose (2%) to give an initial OD600 of 0.001. The plates were 
incubated in a Varioskan (Thermo) plate reader at 37 °C with shaking every 5 minutes.  
The absorbance at 600, 900 and 975 nm was measured every 20 minutes for up to 500 
hours. The baseline absorbance for each well (the average over several smoothed data 
points before growth) was subtracted from each point of the smoothed growth curve. 
Growth parameters (maximum specific growth, µmax; lag time, λ; maximum growth, 
Amax) were estimated by non-linear regression using the modified Gompertz equation 
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(24).  Non-linear least-squares regression was performed in Excel using the Solver 
feature.  
 In order to make the four growth conditions used during my growth curve 
experiment, proline or arginine was added to M9/glucose for a starting concentration 
of.444 mM or 5.777 mM respectively. Consequently, once 10 μL aliquots containing 
cells is added to wells containing 90 µL of the supplemented medium, the final 
concentrations of proline and arginine will be .4 mM and 5.2 mM respectively.  
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Chapter 4 
Determination of proA* copy number of population samples after long-term 
adaptation of the ∆argC proA* S. enterica parental strain in 
 M9/glucose liquid medium 
 
 None of the 100 faster-growing colonies obtained after growth of the ∆argC 
proA* strain of S. enterica on M9/glucose were determined to have amplification of the 
proBA* operon. This is in contrast to a similar experiment involving a ∆argC proA* 
strain of E. coli by Dr. Jamie Kershner in which faster-growing mutants with varying 
sizes and degrees of amplification of the proBA* operon were observed  (Jamie et al., 
2015). The faster-growing colonies analyzed during both these experiments were only 
growing for ~30 generations, but perhaps more time is necessary to see amplification in 
S. enterica. This chapter describes a long term adaptation experiment meant to exhaust 
the question as to whether allowing more time to adapt would result in amplification of 
the proBA* operon and its surrounding regions. To do this, four cell lineages of the 
∆argC proA* parental strain of S. enterica (JK328 and JK329) were grown in 5 mL 
M9/glucose until mid-log, at which point some of the culture was used to inoculate fresh 
5 mL M9/glucose and grown to mid-log again. This was done for ~260 generations over 
the time period of a month. The constructed “wild type” version of S. enterica capable of 
independently producing histidine, JK411, was used as my control. 
 All of the faster-growing colonies obtained after growth of the ∆argC proA* 
strain of S. enterica on plates containing M9/glucose were found to have M2, and I do not 
expect growth in M9/glucose liquid medium to be any different. However, amplification 
 47 
does happen in the ∆argC proA* strain of E. coli containing M2 when adapted further in 
M9/glucose medium (Jamie et al., 2015). Therefore, maybe the same thing can happen in 
a ∆argC proA* strain of S. enterica containing M2 if allowed to adapt further in 
M9/glucose medium.  
Results 
Long-term adaptation suggests three marked levels improvement in growth rate 
 The change in OD600 was used to calculate generations passed during each culture 
and was divided by the time of incubation to determine generations passed per day. These 
values were plotted against the number of generations passed since the start of the long-
term adaptation in order to get a qualitative assessment of their change in growth rate 
(Fig 4.1). Interestingly, all four genetic replicates seem to follow the same pattern of 
increasing growth rate with 3 marked levels of improvement. Furthermore, there appears 
to be one marked improvement in the growth rate of the control.  
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Fig 4.1. Shows changes in growth rate as a function of generations per day during 
adaptation of four S. enterica parental strain lineages (JK328 and JK329) and one WT 
control (JK411). Growth rate was measured as generations per day and plotted over the 
total generations passed since starting adaptation in M9/glucose. Arrows show time 
points when genomic DNA of the population was analyzed by qPCR to determine proA* 
copy number.   
 
Screening the genomic DNA of the population across several time points for increased 
proA* copy number using qPCR reveals no amplification of the proBA* operon 
 In order to check if amplification of the proBA* operon has occurred during the 
course of my long-term adaptation experiment, individual samples from four different 
time point around ~60 generations apart were selected for qPCR analysis (Table 4.1). 
Frozen cell pellets were available for the latter 3 time points, but not for my earliest time 
point. For this time point, a cell pellet was prepared from an aliquot of the freezer stock.  
Samples were screened with the best primer set for each target gene on the same plate in 
order to eliminate the need for inter-run calibrators (Table 2.2). The first and last 
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dilutions of the parental strain JK328 genomic DNA standards were used as the reference 
for determining proA* copy number. Samples were screened without replicates. Primer 
efficiencies and average Ct values for each reaction were exported to Excel for analysis 
with qBASE (11). The mean CNRQ of proA* determined for all samples was 1.05 with a 
s.d. of 0.14, no CNRQ values fell above or below 2 standard deviations of the mean.  
 
Discussion 
 No increase in proA* copy number was observed for any of my parental lineages 
during the time points selected for qPCR analysis. The fact that there was one marked 
improvement in the growth rate of the control is problematic, but can be partially 
explained by how the strain was constructed. The increase in growth rate suggests that 
there is adaptation occurring to M9/glucose which may interfere or confound the actual 
growth rate effects of genetic changes thought to be compensating solely for the 
inefficient bi-functional enzyme ProA*. However, this strain of S. enterica is normally a 
histidine auxotroph due to a nonsense mutation in the coding region of hisG, a gene 
required for the independent production of histidine. In order to allow growth of this 
strain on M9/glucose, Dr. Juhan Kim reversed the mutation using the pSLTS method 
(14). Consequently, it is not unlikely that adaptation would occur in order to re-optimize 
the pathway necessary for histidine production. More importantly, this emphasizes the 
use of genome editing techniques that can allow us to study the effect of genetic changes 
that are observed, like M2, in the absence of other genetic changes that could have 
occurred. 
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 In terms of my parental strain, the three marked improvements in growth rate 
suggest that alternative ways to improve fitness have been selected for. In the future, I 
hope to investigate what genetic changes occurred and how these changes improve fitness 
of the ∆argC proA* strain of S. enterica in M9/glucose. The absence of amplification 
during my long-term adaptation experiment may be due to difference in the genetic 
context between the two bacterial species. For example, it may be that the absence of an 
IS5 transposable element in S. enterica that is consistently observed at the 3’ end of the 
amplified region in E. coli is making amplification of the region less frequent (Jamie et 
al., 2015). Alternatively, amplification of the proBA operon and surrounding regions may 
have serious fitness costs in S. enterica compared to similar amplifications in E. coli due 
to differences in the surrounding genes (8). The later was explored in preliminary 
experiments described in Chapter 5.   
 
 
Methods 
Setting up and running the long-term adaptation experiment 
 Aliquots of freezer stocks of the JK328 and JK329 parental strains were streaked 
onto plates containing LB/strep (50 μg/mL) and incubated overnight at 37 °C. Two 
replicates from each plate (4 genetic replicates) were used to inoculate 2 mL LB/strep (50 
μg/mL) and incubated at 37 °C. Cultures were harvested at mid-log by centrifugation at 
10,000 xg for 1.5 min at room temperature, washed twice with 1 mL ice-cold sterile PBS, 
and suspended in 1 mL ice-cold sterile PBS. The suspensions were used to inoculate 5 
mL M9/glucose (0.2%)/strep (50 μg/mL) to an initial OD600 of 0.001 and incubated at 37 
°C. At mid-log, the OD600 was measured for each culture and the change in OD600 was 
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used to calculate the generations passed during growth of the culture. Then, the amount 
of generations passed was divided by the amount of days passed to calculate generations 
per day. Some of the culture was used to inoculate fresh 5 mL M9/glucose (0.2%)/strep 
(50 μg/mL) medium to an initial OD600 of 0.001 and incubated at 37 °C. 1 mL of each 
culture was used to make freezer stock (10% DMSO (v/v)) while another 1 mL was 
harvested via centrifugation at 10,000 xg for 1.5 min at room temperature, drained of 
supernatant, and stored at -20 °C.  
Four cell lineages of the ∆argC proA* parental strain of S. enterica and one cell 
lineage of my control (JK411, +hisG) were followed in this way for ~250 generations or 
27 cultures over the time period of a month. When cultures started to grow faster, a lower 
initial OD600 of 0.0001 or 0.00001 was used or more transfers were done per day (2 
instead of 1). This is needed to prevent the growth of cultures into stationary phase, 
which interferes with accurate gen/day calculations. When a culture overgrows, a new 
culture can be started from the freezer stock of the previous culture, but requires the use 
of sterile DMSO or antibiotics to prevent contamination of cultures. For my long-term 
experiment, streptomycin was supplemented in all cultures to select against other 
bacterial species.   
Screening genomic DNA of population samples for increased proA* copy number 
 The same primers used during the qPCR in Chapter 2 were used for this 
experiment (Table 2.2). Cycling conditions and settings for the 7500 Fast Real-Time PCR 
System was also maintained. A re-run of the standard curve for all primer sets using 4 
1:10 serial dilutions of JK328 genomic DNA was done in order to generate new and 
reliable primer efficiencies. However, thresholds were manually set to those previously 
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determined via auto-threshold during my adaptation experiment (Table 2.2). Genomic 
DNA was prepped from frozen cell pellets across 4 different time points (gen ~50,  ~125, 
~175, and ~250) for each parental cell lineage using the PureLink Genomic DNA Mini 
Kit (Invitrogen); eluted in 50 µL EB. When a cell pellet does not exist for a cell culture 
(gen ~50), an aliquot of the freezer stock corresponding to that time point can be used to 
inoculate 2 mL M9/glucose (0.2%)/strep (50 μg/mL), grown at 37 °C until mid-log, and 
pelleted by centrifugation at 10,000 xg for 1.5 min at room temperature.  
 Parental lineage samples were screened with the best primer set for each target 
gene on the same plate in order to eliminate the need of inter-run calibrators. Reaction 
mixtures contained 2 µL template, 0.4 µL each of the 10 µM forward and reverse 
primers, 7.2 µL sterile H2O, and 10 µL 2X SYBR green MM (Applied Biosystems). The 
first and last dilutions of the parental strain JK328 genomic DNA standards were used as 
the reference for determining the CNRQ of proA*. The average efficiencies for each 
primer set and the average Ct values for each reaction were exported into Excel for 
analysis with qBase in order to generate the copy number relative quantity (CNRQ) of 
proA* in my population samples (11). The genomic DNA of population samples were 
initially screened without replicates, and those that showed a CNRQ value greater than 
1.5 or less than 0.5 were streaked onto M9/glucose and incubated overnight at 37 °C in 
order to screen single colonies and identify amplification mutants within the population. 
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Chapter 5 
Preliminary investigation of the effects amplification of the proBA* operon has on 
surrounding gene expression in a ∆argC proA* strain of E. coli  
  
 Overexpression of genes within an amplified region could have a detrimental 
effect if it interferes with highly constrained cellular systems and hence be selectively 
unfavorable (8). However, if cells are limited by the ability of an enzyme to sufficiently 
produce metabolites or clear toxins, amplification could increase fitness by increasing 
gene dosage (17). Consequently, selection could favor amplification when its benefit 
outweighs the cost. For example, various amplifications of the proBA* operon were 
identified in faster-growing colonies after growth of a ∆argC proA* strain of Escherichia 
coli BW25113 on M9/glucose. The segmental amplifications were determined to be very 
large (~30 kb) and to include genes upstream and downstream of proBA* (Jamie et al., 
2015). In contrast, no amplification of the proBA* operon was found in faster-growing 
colonies after growth of the ∆argC proA* S. enterica strain in M9/glucose for ~250 
generations (Chapter 4). In addition, the genetic context of the proBA* operon is different 
between the two bacterial species, especially the downstream region (Fig 2.4). It is 
unknown whether these large amplifications in E. coli are causing overexpression of 
genes within the amplified segment. If they are, then the genetic context becomes 
important for determining the cost of amplification and the potential of certain 
evolutionary trajectories when the growth of cells are limited by an inefficient bi-
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functional enzyme. However, if some homeostatic mechanism keeps protein expression 
at a constant level, then this would suggest that the genetic context may not be important.  
 In this chapter, I describe preliminary experiments testing whether expression of 
genes within the amplified region increases as gene copy number increases or if 
homeostatic mechanisms keep protein expression at a constant level. To do this, I 
selected two amplification mutants identified after growth of a ∆argC proA* strain of E. 
coli on M9/glucose, JKAD 1-17-1 T4 (A1) and JKAD 3-4-2 t4 (A3), with varying 
amounts of amplification determined previously by qPCR analysis (60-80 and 13-15 
copies of proA* respectively). Aliquots of cells from a freezer stock of A1 and A3 were 
used to inoculate M9/glucose medium and cultured until an OD600 of 0.2, at which point 
they were harvested and used to make genomic DNA or prepare tryptic digests for mass 
spectroscopy analysis. proA* copy number was determined by qPCR analysis of the 
genomic DNA and compared to fold-changes in relative protein levels determined by 
label-free mass spectrometry of tryptic digests. Label-free mass spectrometry has been 
gaining attention as a way to quantitatively compare protein levels as technological 
advances allow greater resolution of whole cell peptide spectra and more databases to 
search against. Viable methods for prepping samples for label-free mass spectrometry 
and analysis of spectral counts are documented in the literature (20, 21, 22). 
Alternatively, mass spectrometry using spiked standards is more accurate, but these 
methods are time-consuming and expensive. 
   
 
 
 55 
Results 
Mass spectrometry analysis results in various coverage of the proteins encoded in genes 
within the amplified segments of JKAD 1-17-1 t4 and JKAD 3-4-2 t4 
 I examined the effect amplification of the proBA* operon had on surrounding 
gene expression by label-free mass spectrometry analysis of tryptic digests prepared from 
cell extracts of JKAD 1-17-1 t4 and JKAD 3-4-2 t4. I prepared the trypic digests from 
cell extracts and Dr. Christopher Ebmeier analyzed them on an LTQ-Orbitrap mass 
spectrometer (Thermo Scientific). Dr. Ebmeier searched identified spectra against an E. 
coli database using Mascot software (Matrix Sciences) to identify peaks corresponding to 
peptides from all known proteins.  The two amplification mutants described in this 
experiment, JKAD 1-17-1 t4 and JKAD 3-4-2 t4, have different sizes of amplification 
ending at the same downstream element. I was only interested in genes that were 
included in the amplified region of both amplification mutants (Fig 5.1). More than 
22,000 unique peptides were detected that could be unambiguously assigned to various 
proteins, 25 unique peptides that could be unambiguously assigned to ProA (73.4% 
coverage), and 33 unique peptides that could be unambiguously assigned to ProB (87.5% 
coverage). There were no unique peptides identified that could be assigned to proteins 
expressed from genes downstream of the proBA* operon. For proteins that are expressed 
from genes upstream of the proBA* operon, 16 unique peptides could be unambiguously 
assigned to Crl (72.18% coverage), 35 unique peptides could be unambiguously assigned 
to FrsA (89.6% coverage), 9 unique peptides could be unambiguously assigned to Gpt 
(58.6% coverage), and 33 unique peptides could be unambiguously assigned to PepD 
(65.4% coverage).  
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Fig 5.1. Genes (in the upstream region) chosen as good candidates for comparing mean 
normalized spectral counts between E. coli amplification mutants JKAD 1-17-1 t4 (A1 - 
amplified region) or JKAD 3-4-2 t4 (A3 – amplified region) and the wild type strain of E. 
coli BW25113. 
 
Normalized spectral counts can be compared between the wild type strain of E. coli and 
JKAD 1-17-1 t4 or JKAD 3-4-2 t4 strains to determine the fold-change in relative protein 
levels 
 Spectral counts for each protein for each sample were normalized to the mean 
total spectral counts of all samples. The normalized spectral counts determined for a 
given protein were compared between the wild type strain of Escherichia coli BW25113 
and JKAD 1-17-1 t4 or JKAD 3-4-2 t4 to determine fold-changes in relative protein 
levels. This was done for spectral counts of ProA, ProB, Crl, FrsA, Gpt, and PepD. These 
proteins are expressed from genes surrounding the proBA operon that are amplified in 
both strains (Fig 5.1). JKAD 1-17-1 t4 and JKAD 3-4-2 t4 show an increase in ProA and 
ProB relative protein levels compared to the WT. Interestingly, there was no increase in 
the protein levels of Crl, FrsA, Gpt, and PepD in tryptic digests of the JKAD 3-4-2 t4 
amplification mutant, but varying increases in these protein levels in tryptic digests of the 
JKAD 1-17-1 t4 amplification mutant (Fig 5.2).  
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Fig 5.2. Fold-changes in relative protein levels by comparing normalized mean 
spectral counts of each protein of each strain to the wild type E. coli. Red, fold-
changes in levels of the indicated proteins in JKAD 1-17-1 t4, which was determined 
by qPCR to have a proA* copy number of 63. Blue, fold-changes in relative protein 
levels of JKAD 3-4-2 t4, which was determined by qPCR to have a proA* copy 
number of 16. Green, fold-changes in relative protein levels of the wild type strain of 
E. coli BW25113, which has a proA* copy number of 1.  
 
Determination of proA* copy number from genomic DNA of JKAD 1-17-1 t4 and JKAD 
3-4-2 t4 and comparison to fold-changes in relative protein levels of ProA* and ProB 
 qPCR was used to determine the proA* copy number from genomic DNA of 
∆argC proA* E. coli amplification mutants JKAD 1-17-1 t4 (A1) and JKAD 3-4-2 t4 
(A3) using icdA and gyrB as internal reference genes. The primers used were obtained 
from Dr. Jamie Kershner and are listed in the Supplemental Information (Table S.2). The 
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genomic DNA from the ∆argC proA* E. coli parental strain (JK293) was used as the 
reference for determining the proA* copy number of the amplification strains. Primer 
efficiencies and average Ct values for each reaction were exported to Excel for analysis 
with qBASE (11). The proA* CNRQ values determined for JKAD 1-17-1 t4 and JKAD 
3-4-2 t4 were 63 and 16 respectively. Previously reported proA* copy numbers for JKAD 
1-17-1 t4 and JKAD 3-4-2 t4 by Dr. Jamie Kershner were 60-80 and 13-15 respectively. 
 proA* copy number of the ∆argC proA* E. coli amplification strains was 
compared to fold-changes in the relative protein levels of ProA and ProB (Fig 5.3). In 
order to make an equivalent comparison with the other genes in the amplified region, I 
would need to do qPCR analysis with primers that target them specifically. The change in 
proA* copy number does not directly correlate with the fold-change in relative protein 
levels of ProA* and ProB in the JKAD 1-17-1 t4 amplification strain. The change in 
proA* copy number seems to correlate to the fold-change in relative protein levels of 
ProA* and ProB in the JKAD 3-4-2 t4 amplification strain, but I need more biological 
replicates to be confident in my analysis. 
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Fig 5.3. Comparison of proA* copy number and fold-change in relative protein levels 
of ProA and ProB for the two amplification strains, JKAD 1-17-1 t4 and JKAD 3-4-2 
t4. Blue, proA* copy number; red, fold-changes in levels of the indicated proteins. 
 
Discussion 
 The experiments described in this chapter explored the effects amplification of the 
region surrounding the proBA* operon has on the levels of proteins expressed from genes 
in the amplified region in a ∆argC proA* strain of E. coli. I determined the fold-change 
in relative protein levels of my amplification strains by comparison to the wild type strain 
of E. coli, which has an unmodified argC and proA allele. This was chosen over the 
∆argC proA* parental strain of E. coli (JK293) because the proBA operon and 
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surrounding regions can amplify in this strain during growth in M9/glucose. In retrospect, 
I think such a comparison can be made if qPCR analysis of genomic DNA from JK293 
cells cultured in M9/glucose is done prior mass spectrometry analysis on tryptic digests 
prepared from the same cells to show that no amplification of the proBA* operon has 
occurred. The ∆argC proA* parental strain of E. coli (JK293) would allow me to see the 
effect of amplification alone on ProA* and ProB expression. In addition, I would want to 
have more biological replicates to be more confident in my quantification of proA* copy 
number and fold-changes in relative protein levels.  
Interestingly, there seems to be little to no expression of genes between the 
proBA* operon and the conserved downstream junction of the amplified regions. This is 
important considering that this region is different in S. enterica (Fig 5.1). Furthermore, 
there is a stark difference in the expression of genes upstream of the proBA* operon 
between my two amplification mutants. It is unlikely that some homeostatic mechanism 
is affecting one amplification mutant and not the other. Furthermore, I am not sure that 
these genes are present in multiple copies; qPCR was only used to determined proA* 
copy number. In order to see if these genes are also present in multiple copies, I plan to 
design primers that target them specifically. In addition, it would be important to repeat 
the experiment using multiple biological replicates showing the same pattern of 
expression to be confident that what I see is accurate.  
 
Methods 
Preparing strains for qPCR and label-free mass spectrometry 
 An aliquot of a freezer stock of JK1 was streaked onto plates containing 
M9/glucose (0.2%) and incubated overnight at 37 °C. Aliquots of freezer stocks for two 
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amplification strains, JKAD 1-17-1 t4 (A1) and JKAD 3-4-2 t4 (A3), were streaked onto 
plates containing M9/glucose (0.2%)/kan (20 μg/mL) and incubated overnight at 37 °C.  
 A single colony from overnight plates of each strain was suspended in 50 µl 
sterile H2O. Five µl was used to inoculate 2 mL M9/glucose (0.2%) and incubated at 37 
°C until mid-log phase (OD600 of 0.5). Kan 20 μg/mL was supplemented in medium used 
to culture the amplification strains. Two µL of the 2 mL culture was used to inoculate 50 
mL M9/glucose (0.2%) and incubated at 37 °C with shaking to an OD600 of 0.2, at which 
point, 4 x 10 mL aliquots of the 50 mL culture were pelleted via centrifugation at 4,500 
xg for 10 min at 4 °C and stored at -80 °C prior to preparation for Mass Spectrometry. In 
addition, 2 ml of the same 50 mL culture were harvested for the WT and amplification 
strains via centrifugation at 10,000 xg for 2 min at room temperature for genomic DNA 
purification using the PureLink Genomic DNA Mini Kit (Invitrogen); the purified 
genomic DNA was eluted in 50 µL EB. 
qPCR  
 The primers used by Dr. Jamie Kershner for screening mutants via qPCR were 
used for this experiment. Information on these primers can be found in the Supplemental 
Information (Table S.2). qPCR was performed on a 7500 Fast real-time PCR system. A 
re-run of the standard curve for all primer sets was done using four 1:10 serial dilutions 
of the JK1 genomic DNA in triplicate as my standards to generate new and reliable 
primer efficiencies. However, thresholds were manually set to those previously used by 
Dr. Kershner.  Samples were screened with each primer set for each target gene on the 
same plate in order to eliminate the need for inter-run calibrators. Reaction mixtures 
contained 2 µL template, 0.4 µL each of the 10 µM forward and reverse primers, 7.2 µL 
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sterile H2O, and 10 µL 2x SYBR green MM (Applied Biosystems). The first and last 
dilutions of the JK1 genomic DNA standards were used as a reference to determine the 
proA* copy number of the amplification strains. Primer efficiencies and the average Ct 
values for each reaction were exported into Excel for analysis with qBase in order to 
generate the copy number relative quantity of proA* for each sample (11).  
Preparation of tryptic digests for Mass Spectrometry 
 Frozen cell pellets from 10 mL of cultures cells (OD600: 0.2) were suspended in 
200 µL 4% SDS, 0.1 M Tris-pH 8.5, 10 mM TCEP, 40 mM 2-chloroacetamide, and 
sonicated for 1 min using the Branson Sonifier 250 (50% duty, 2.5 output). The samples 
were boiled for 10 min at 95 °C and then kept at room temperature. A Millipore 30kD 
MWCO Amicon Ultra-0.5 centrifugal filter device was prepared by washing it with 300 
µL of 8M urea in 0.1M Tris-pH 8.5 and spinning it, along with your sample, at 16,000 xg 
for 5 min at room temperature. Next, 500 µL of 8 M urea in 0.1 M Tris-pH 8.5 and 50 µl 
of the sample supernatant were added immediately and the device was centrifuged at 
16,000 xg for 10 min at room temperature. The filter was then washed three times with 
300 µL of 8 M urea in 0.1 M Tris-pH 8.5 and three times with 300 µL of 2 M urea in 0.1 
M Tris-pH 8.5. The filter was transferred to a fresh collection tube for sample digestion. 
Next, 200 µl of 2 M urea in 0.1 M Tris-pH 8.5 was added along with 1 μg lysyl 
endopeptidase (Wako) at a ratio of approximately 1:50 (protein: protease) and incubated 
at room temperature for 3 hrs. Then, 1 μg of Trypsin (Promega) at a ratio of 
approximately 1:50 (protein: protease) was added and the filter was incubated overnight 
rocking at room temperature. In the morning, the column was centrifuged at 16,000 xg 
for 10 min at room termperature, 200 µl of 0.5 M NaCl was added to the column, and it 
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was centrifuged again at 16,000 xg for 10 min at room temperature to elute sample. 
Samples were cooled with liquid nitrogen and stored immediately at -80 °C.   
 A Pierce C18 spin column was used to desalt and wash the digested peptides for 
label-free mass spectrometry. First, the column was centrifuged at 300 xg for 1.5 min at 
room temperature in order to settle the resin to the bottom of the column. Then the 
column was equilibrated by washing it twice with 300 µL of 70% ACN and three times 
with 300 µL of 5% ACN using centrifugation at 300 xg for 1.5 min at room temperature 
prior to loading the sample. The entire sample was then loaded onto the column, 
centrifuged at 300 xg for 1.5 min at room temperature, and then re-applied and 
centrifuged again to ensure optimal binding of peptides to the resin. The column was 
washed 5 times with 300 µL of 5% ACN before moving the column into a clean, low-
protein-binding tube. Fifty µL of 70% ACN was added to the column, centrifuged at 300 
xg for 1.5 min at room temperature, and then repeated with another 50 µL of 70% ACN 
to obtain a total of 100 µl of eluted peptides. The samples were frozen with liquid 
nitrogen and stored immediately at -80 °C prior to mass spectrometry. The peptide 
mixture was evaporated to dryness in a Speed-Vac and re-suspended in 0.1% (v/v) formic 
acid in HPLC grade water. Dr. Christopher Ebmeier then injected aliquots containing 2 
μg of peptides onto a C18 UPLC column (Waters nanoAcuity 1.7 µm BEH130, 75 µm x 
250 mm).  The column was eluted with a gradient from 3% to 33% acetonitrile at 0.3 µL 
per minute over a period of five hours.  Eluted peptides were detected using an LTQ-
Orbitrap (Thermo Scientific).  Spectra were searched against an E. coli database using 
Mascot software (Matrix Sciences) to identify peaks corresponding to peptides from all 
known proteins 
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Supplemental Information 
Strain Genotype Reference Notes 
JK328 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG This work S. enterica "parent strain" 
JK329 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG This work S. enterica "parent strain" 
JK411 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
+hisG This work 
S. enterica "wild type" 
(+hisG) 
JC67 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; has M2 This work 
A M2 mutant from my 
adaptation experiment 
JC518 
E. coli MACH1 w/ M1 mutation 
template plasmid This work 
M1 mutation template 
plasmid transformant 
made during my genome 
editing experiment 
JC546 
E. coli MACH1 w/ M2 mutation 
template plasmid This work 
M2 mutation template 
plasmid transformant 
made during my genome 
editing experiment 
    
JC519 
E. coli MACH1 w/ M3 mutation 
template plasmid This work 
M3 mutation template 
plasmid transformant 
made during my genome 
editing experiment 
JC517 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS This work 
Contains the pSLTS 
plasmid necessary for λ-
red recombinase 
expression.  
JC520 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M1 mutation cassette This work 
Has integrated the M1 
mutation cassette and 
selection marker (CAT) 
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JC521 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M1 mutation cassette This work 
Has integrated the M1 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC522 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M1 mutation cassette This work 
Has integrated the M1 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC551 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M2 mutation cassette This work 
Has integrated the M1 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC554 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M2 mutation cassette This work 
Has integrated the M2 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC555 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M2 mutation cassette This work 
Has integrated the M2 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC556 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M2 mutation cassette This work 
Has integrated the M2 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
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Strain Genotype Reference Notes 
JC523 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M3 mutation cassette This work 
Has integrated the M3 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC524 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M3 mutation cassette This work 
Has integrated the M3 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC525 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M3 mutation cassette This work 
Has integrated the M3 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC526 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; +pSLTS; 
+M3 mutation cassette This work 
Has integrated the M3 
mutation cassette and 
selection marker (CAT); 
genome editing 
experiment 
JC543 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; M1 This work 
The pSLTS plasmid has 
been remove M1 has 
been inserted; genome 
editing experiment 
JC559 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; M2 This work 
The pSLTS plasmid has 
been remove M2 has 
been inserted; genome 
editing experiment 
JC560 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; M2 This work 
The pSLTS plasmid has 
been remove M2 has 
been inserted; genome 
editing experiment 
JC544 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; M3 This work 
The pSLTS plasmid has 
been remove M3 has 
been inserted; genome 
editing experiment 
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JC545 
Salmonella enterica subsp. enterica 
serovar Typhimurium str. SL1344; 
ΔargC; E382A ProA; +hisG; M3 This work 
The pSLTS plasmid has 
been remove M3 has 
been inserted; genome 
editing experiment 
JKAD 
1-17-1 
t4 
Escherichia coli BW25113; ΔargC; 
E383A ProA; proBA amplification  
Jamie et 
al., 2015 
E. coli amplification 
mutant (60-80 copies) 
JKAD 
3-4-2 
t4 
Escherichia coli BW25113; ΔargC; 
E383A ProA; proBA amplification  
Jamie et 
al., 2015 
E. coli amplification 
mutant (13-15) 
JK1 Escherichia coli BW25113 
Jamie et 
al., 2015 E. coli WT 
JK293 
Escherichia coli BW25113; ΔargC; 
E383A ProA 
Jamie et 
al., 2015 E. coli "parent strain" 
Fig S.1. List of all strains used in this thesis including their name, genotype, source, 
and notes 
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Primer 
Name 
Direction 
(Forward 
or 
Reverse) Sequence (5'->3') Reference Notes 
JC-P11 Forward GCGTCCGAATGTTACCGTTG  This work proAset1; qPCR 
JC-P12 Reverse TTCCCACCGCGTAGAATCAC This work proAset1; qPCR 
JC-P13 Forward TGCGCCAGGTCTGTAATCTC This work proAset2; qPCR 
JC-P14 Reverse CAACGGTAACATTCGGACGC This work proAset2; qPCR 
JC-P5 Forward CAGGCGGAGCTTATCAAAGA This work proAset3; qPCR 
JC-P6 Reverse CCTGAAGCTTAGTGCTCATACC This work proAset3; qPCR 
JC-P15 Forward TCGTTACTATCAGGGCACGC This work icdAset1; qPCR 
JC-P16 Reverse TCCGGCGTAGATGTCTTCAG This work icdAset1; qPCR 
JC-P17 Forward CGCCTGTATGAACCTGAACG This work icdAset2; qPCR 
JC-P18 Reverse GCAATACCGATACCGCCAAC This work icdAset2; qPCR 
JC-P7 Forward GCCGTCGAGAAAGCCTATAA This work icdAset3; qPCR 
JC-P8 Reverse CAGACATCCTGGCCGTAAA This work icdAset3; qPCR 
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JC-P19 Forward 
TGCCCGTGAAGGTCTGATT
G This work gyrBset1; qPCR 
JC-P20 Reverse TCATCTGCTGTTCTACCGCC This work gyrBset1; qPCR 
JC-P21 Forward 
TGCCCGTGAAGGTCTGATT
G This work gyrBset2; qPCR 
JC-P22 Reverse GCTGTTCTACCGCCGATTTC This work gyrBset2; qPCR 
JC-P23 Forward CGCTGCTGTTGACCTTCTTC This work gyrBset3; qPCR 
JC-P24 Reverse ACTGATCCATCGCTTCGTCG This work gyrBset3; qPCR 
JC-P25 Forward CCACTATTGCCAGAGTGC This work 
PCR-amplify proBA 
operon and regulatory 
region for short-read 
sequencing (5' region) 
JC-P28 Reverse CAGCAATCGCTTTCAGACG This work 
PCR-amplify proBA 
operon and regulatory 
region for short-read 
sequencing (5' region) 
JC-P2 Forward ACCCGAGAGTGTACCCGAG This work 
PCR-amplify proBA 
operon and regulatory 
region for short-read 
sequencing (3' region) 
JC-P3 Reverse AACGTGGCAGTTCACTTCTG This work 
PCR-amplify proBA 
operon and regulatory 
region for short-read 
sequencing (3' region) 
JC-P37 Forward 
AGGCGTATCACGAGGCCCTT
ACGTTCGGTAATGAAAGAT This work 
PCR-amplify upstream 
region of M2 
mutation template 
plasmid; Chapter 3 
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Primer 
Name 
Direction 
(Forward 
or 
Reverse) Sequence (5'->3') Reference Notes 
JC-P38 Reverse 
ACCGCTGCCACTC
TTGAGATTAAAGA
CCAAATGAACATT This work 
PCR-amplify upstream region 
of M2 mutation template 
plasmid; Chapter 3 
JC-P39 Forward 
GTGGCAGGGCGGG
GCGTAAGCCAGTC
CTGCTAAAATGTT
C This work 
PCR-amplify downstream 
region of M2 mutation 
template plasmid; Chapter 3 
JC-P40 Reverse 
CTCACATGTTCTT
TCCTGCGATGTCC
CGCGGCGTGTAAC
TGCG This work 
PCR-amplify downstream 
region of M2 mutation 
template plasmid; Chapter 3 
pHA.se
q.F Forward 
TATCAGGGTTATTG
TCTCATGAGCG 
Dr. Juhan 
Kim (17) 
Amplify segment of mutation 
template plasmid containing 
the mutation cassette; 
Chapter 3 
pHA.se
q.R Reverse 
ACTTGAGCGTCGAT
TTTTGTGATGC 
Dr. Juhan 
Kim (17) 
Amplify segment of mutation 
template plasmid containing 
the mutation cassette; 
Chapter 3 
JC-P29 Forward 
TATGTTTAATTGT
TGCGGTAA This work 
Amplify M1 mutation 
cassette; Chapter 3 
JC-P30 Reverse 
CCGAGTTTTACGA
CCA This work 
Amplify M1 mutation 
cassette; Chapter 3 
JC-P41 Forward 
GTTGCGGTAATAA
AATGGTCAAATTC
CGC This work 
Amplify M2 mutation 
cassette; Chapter 3 
JC-P42 Reverse 
CGATCCGCCTGTT
AGCACGC This work 
Amplify M2 mutation 
cassette; Chapter 3 
JC-P31 Forward 
GAGGTCATCAGAA
TTTG This work 
Amplify M3 mutation 
cassette; Chapter 3 
JC-P32 Reverse 
CTTTAGCAGCAAT
GC This work 
Amplify M3 mutation 
cassette; Chapter 3 
JC-P33 Forward 
CACTTTCGGCTTTAT
TACTGGC This work 
Verify M1 and M2 insertion; 
Chapter 3 
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JC-P34 Reverse 
GATTGCTACGCGGA
TCGG This work 
Verify M1 and M2 insertion; 
Chapter 3 
JC-P35 Forward 
GTGTATGGCGTTGA
CGATG This work 
Verify M3 insertion; Chapter 
3 
JC-P36 Reverse 
GTAGAATCACCGCA
TTACCG This work 
Verify M3 insertion; Chapter 
3 
1357 Forward 
CGTGCAGGCGATTG
ATAA 
Jamie et al., 
2015 E. coli proA qPCR; Chapter 5 
1359 Reverse 
CTGTTCACGGCACA
GTTT 
Jamie et al., 
2015 E. coli proA qPCR; Chapter 5 
1361 Forward 
CCCGTGGCTGAAAG
TTAAA 
Jamie et al., 
2015 E. coli icdA qPCR; Chapter 5 
1362 Reverse 
CAGGTTCATACAGG
CGATAAC 
Jamie et al., 
2015 E. coli icdA qPCR; Chapter 5 
1359 Forward 
CGTAGATCTGACGG
TGAATTT 
Jamie et al., 
2015) E. coli gyrB qPCR; Chapter 5 
1360 Reverse 
CGTTGGTGTTTCGGT
AGTA 
Jamie et al., 
2015 E. coli gyrB qPCR; Chapter 5 
Fig S.2. List of all primers used in this thesis including their name, direction, 
sequence, source, and description 
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